Placement to Raise $3.25 million
Filed with ASX · · 2 pages · English
Control Bionics Limited (ASX: CBL) (“Control Bionics” or “the Company”) is pleased to announce it has successfully completed a private placement of 50,000,000 new fully paid ordinary shares at an issue price of $0.065 per share, raising $3.25 million. This represents a discount of approximately 6.4% to the 5-day VWAP of CBL shares traded on the ASX up to 28 November 2025. The placement was complet
Earlier from Control Bionics
- Control Bionics Integrates with Apple BCI Protocol
- Rights Issue Offer Booklet
- Preliminary Final Report
- Non-Renounceable Rights Issue
- FY25 Trading Update and NeuroStrip Progress
Later from Control Bionics
- Acquisition of Full Ownership of Neuro Elite Athletics
- Tobii Dynavox - Distribution Partnership
- Quarterly Activities/Appendix 4C Cash Flow Report
- PRC-Saltillo - Distribution Agreement
- Half Yearly Report and Accounts
Follow Control Bionics into a list and get an email when it puts out news.
Follow Control Bionics